Medical device landscape for communicable and noncommunicable diseases in low-income countries.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
infectious disease 9 infectiousdiseases
AIDS 1 infectiousdiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
AIDS 8860 total 134 commercialized devices, 114 (85%) targeted infectious diseases or MDG 4 or MDG 5. The HIV/ AIDS topic had the largest number of commercialized devices (36), with the majority in the diagnostic category
infectious disease 1011 commercialized devices exclusively designed for use in LICs. More than 85% of devices were designed to address infectious disease s or child or maternal health (MDG 4 or 5, respectively). None of the identified devices addressed prevention
infectious disease 3863 levels, and planning strategic interventions globally have led to drastic reductions in mortality due to infectious disease s, maternal and child illness, and malnutrition [[9]]. While infectious diseases have been in the spotlight
infectious disease 3942 in mortality due to infectious diseases, maternal and child illness, and malnutrition [[9]]. While infectious disease s have been in the spotlight for the last few decades, noncommunicable diseases (NCDs) accounted for
infectious disease 4376 three times as many disability-adjusted life years (DALYs) and nearly five times as many deaths as infectious disease s, maternal, perinatal, and nutritional conditions combined [[10]]. Given these projections, the WHO
infectious disease 8654 their associated scope (i.e., diagnostic, prevention, and treatment), and mortality projections for infectious disease s, NCDs, pregnancy-related complications, and newborn conditions in LICs [[19]]. Of the total 134 commercialized
infectious disease 8813 and newborn conditions in LICs [[19]]. Of the total 134 commercialized devices, 114 (85%) targeted infectious disease s or MDG 4 or MDG 5. The HIV/AIDS topic had the largest number of commercialized devices (36), with the
infectious disease 9177 topic. Other than for the waterborne diseases topic, there was only one device-based treatment for infectious disease s.Fig. 1The left side bar graphs show the actual (2005) and projected (2015 and 2030) mortality in LICs
infectious disease 12355 is considerably smaller than the number designed and commercialized to prevent, diagnose, and treat infectious disease s, maternal health, and infant health.There is a critical gap between designing and developing a safe
infectious disease 17398 still effective in addressing health challenges. The focus on actual and projected mortality due to infectious disease s, NCDs, pregnancy-related complications, and newborn conditions in LICs did not consider the DALYs,

You must be authorized to submit a review.